- Home
- ENLT vs OMCL Comparison
ENLT vs OMCL Comparison
Compare ENLT & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ENLT | OMCL |
|---|---|---|
| Founded | 2008 | 1992 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | | Computer Manufacturing |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 2.1B |
| IPO Year | 2023 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ENLT | OMCL |
|---|---|---|
| Price | $50.57 | $50.77 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $37.50 | ★ $49.83 |
| AVG Volume (30 Days) | 47.3K | ★ 568.3K |
| Earning Date | 02-18-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 132.72 | N/A |
| EPS | ★ 0.96 | 0.43 |
| Revenue | $457,756,000.00 | ★ $1,177,740,000.00 |
| Revenue This Year | $355.90 | $8.61 |
| Revenue Next Year | $42.83 | $4.22 |
| P/E Ratio | ★ $54.77 | $120.80 |
| Revenue Growth | ★ 27.72 | 10.67 |
| 52 Week Low | $14.01 | $22.66 |
| 52 Week High | $52.92 | $55.00 |
Technical Indicators
Market Signals| Indicator | ENLT | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 66.18 | 72.70 |
| Support Level | $49.98 | $49.00 |
| Resistance Level | $52.92 | $51.84 |
| Average True Range (ATR) | 1.39 | 1.30 |
| MACD | 0.34 | 0.17 |
| Stochastic Oscillator | 81.35 | 82.43 |
Price Performance
Historical ComparisonAbout ENLT Enlight Renewable Energy Ltd.
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, which produces its revenue from the sale of the electricity that is produced through wind energy and solar energy in Europe.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.